SCHEMBL729385

SCHEMBL729385

[O]CCN1CCCC1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1446405 0.93 L3MBTL1 (0.47) —
SCHEMBL261644 0.87 PIK3CD (0.58) —
SCHEMBL730495 0.86 PIK3CD (0.48) —
SCHEMBL16612410 0.85 — —
SCHEMBL4397526 0.85 PIK3CD (0.47) —
SCHEMBL5044334 0.84 — —
SCHEMBL5424673 0.83 PIK3CD (0.54) —
SCHEMBL19514132 0.81 PIK3CD (0.52) —
SCHEMBL989008 0.81 PIK3CD (0.52) —
SCHEMBL31632694 0.81 PIK3CD (0.52) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 291 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117229205-A Preparation method and pharmaceutical application of phenyl acrylamide RHbDD1 inhibitor 中国医学科学院基础医学研究所 2023-12-15 — — CN claimed
US-20170029409-A1 COMPOSITIONS USEFUL FOR TREATING DISORDERS RELATED TO KIT BLUEPRINT MEDICINES CORPORATION 2017-02-02 — — US claimed
US-9499522-B2 Compositions useful for treating disorders related to kit BLUEPRINT MEDICINES CORPORATION (US) 2016-11-22 — — US claimed
US-9139567-B2 Arylpyrazole ethers as inhibitors of leukotriene A4 hydrolase BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2015-09-22 — — US claimed
US-8907096-B2 N-adamantyl benzamides as inhibitors of 11-β-hydroxysteroid dehydrogenase HIGH POINT PHARMACEUTICALS, LLC (US) 2014-12-09 — — US claimed
US-20140315905-A1 N-ADAMANTYL BENZAMIDES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE VTV THERAPEUTICS LLC 2014-10-23 — — US claimed
US-20140296206-A1 COMPOSITIONS USEFUL FOR TREATING DISORDERS RELATED TO KIT BLUEPRINT MEDICINES CORPORATION (US) 2014-10-02 — — US claimed
US-8809540-B2 N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase HIGH POINT PHARMACEUTICALS, LLC (US) 2014-08-19 — — US claimed
US-20140221373-A1 ARYLPYRAZOLE ETHERS AS INHIBITORS OF LEUKOTRIENE A4 HYDROLASE BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-08-07 — — US claimed
EP-2734516-A1 ARYLPYRAZOLE ETHERS AS INHIBITORS OF LEUKOTRIENE A4 HYDROLASE Boehringer Ingelheim International GmbH (DE) 2014-05-28 — — EP claimed
US-6444696-B1 1-ARYL OR HETEROARYL SUBSTITUTED 5-AMINO-4 CARBONYLPYRAZOLE DERIVATIVES; ANTIINFLAMMATORY AGENTS SYNTEX (U.S.A.) LLC 2002-09-03 — — US claimed
US-20020103245-A1 Pyrazole derivatives P38 MAP kinase inhibitors GOLDSTEIN DAVID MICHAEL (US) 2002-08-01 — — US claimed
US-6350774-B1 Antithrombotic agents ELI LILLY AND COMPANY 2002-02-26 — — US claimed
US-6316466-B1 Pyrazole derivatives P-38 MAP kinase inhibitors SYNTEX (U.S.A.) LLC 2001-11-13 — — US claimed
WO-2001036414-A1 ANTITHROMBOTIC AGENTS ELI LILLY AND COMPANY (US) 2001-05-25 — — WO claimed
EP-0980367-A1 ANTITHROMBOTIC AGENTS ELI LILLY AND COMPANY (US) 2000-02-23 — — EP claimed
US-5965598-A PHOTOTHERAPEUTIC AND PHOTODIAGNOSTIC AGENTS AS FREE MOLECULES AND AS CONJUGATES WITH MACROMOLECULAR CARRIER MOLECULES MOLTENI L. & C. DEI FRATELLI ALITTI SOCIETA DI ESERCIZIO S.P.A. (IT) 1999-10-12 — — US claimed
EP-0906758-A1 Zinc-phthalocyanines and corresponding conjugates, their preparation and use in photodynamic therapy and as diagnostic agents MOLTENI L. &amp; C. dei Fratelli Alitti Società di Esercizio S.P.A. (IT) 1999-04-07 — — EP claimed
WO-1998049161-A1 ANTITHROMBOTIC AGENTS ELI LILLY AND COMPANY (US) 1998-11-05 — — WO claimed
EP-0483667-B1 Cyclic imino derivatives, process for their preparation and drugs containing them THOMAE GMBH DR K (DE) 1998-02-04 — — EP claimed
Send feedback